News
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
Developers specifically placed the sculpture in the city in a bid to attract both locals and tourists to the area and rebuild its reputation.
President Trump has elevated an issue Democrats have been jawboning about for years. On Monday the president issued an ...
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
In a social media post on Sunday evening, Trump said he would sign an order on Monday to reduce prices “almost immediately by ...
2d
The Daily Caller on MSNMegyn Kelly Guest Tells Why Bernie Sanders Must ‘Get His Butt Over To The White House’ For Trump’s Drug CutsEditor-at-large for “County Highway” Walter Kirn told SiriusXM’s Megyn Kelly on Monday that Independent Vermont Sen. Bernie ...
Ozempic's double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms
Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...
The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting the disease. Scientists from Israel said the drugs, also known as GLP ...
The explosive popularity of GLP-1 (Glucagon-Like Peptide-1) drugs for addressing weight loss, diabetes and obesity, such as Ozempic and Munjaro are useful for a limited number of people and will ...
Novo Nordisk A/S is partnering with US biotech Septerna Inc. on the development of oral pills for obesity and type-2 diabetes ...
Novo Nordisk was previously sued in 2023, along with competitor Eli Lilly, by a patient with severe gastrointestinal side effects after taking Ozempic and Lily's Mounjaro. That lawsuit is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results